Reims, France · Founded 2019 · Privately Held (backing)
Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. Apmonia Therapeutics is based in Reims, France and was founded in 2019. Its last reported valuation was $26.8 million in Oct 2025. It has raised $23.9 million.
Last reported valuation
$26.8M
Oct 2026
Priced at
—
Total raised
$23.9M
Last round
—
Cap table — not yet on record
Apmonia Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Apmonia Therapeutics with a free account
·The complete investor list: 12 names
·Watch Apmonia Therapeutics: the Monday email on marks, rounds and moves
